<DOC>
	<DOCNO>NCT00404378</DOCNO>
	<brief_summary>This two period study healthy adult subject characterize effect dose ketoconazole way body react dose GW679769 , assess safety profile oral casopitant without ketoconazole . This study consist screen period , two treatment period post-treatment follow-up visit .</brief_summary>
	<brief_title>Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant GW679769</brief_title>
	<detailed_description />
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Ketoconazole</mesh_term>
	<mesh_term>Casopitant</mesh_term>
	<criteria>Healthy male female Females must nonchildbearing potential Adequate organ function Able swallow retain oral medication Able understand comply study requirement Signed ICF Clinically relevant abnormality identify screen exam medical condition circumstance make subject unsuitable participation study . History drug allergy contraindicate participation . Known immediate hypersensitivity reaction idiosyncrasy GW679769 ketoconazole drug chemically relate study medication . Use investigational drug within 28 day precede first dose GW679769 ketoconazole participation another clinical trial within past 30 day . Blood donation excess 1 pint within 56 day prior first dose study medication intend donate within 30 day posttreatment followup visit . History suspect iron deficiency . Positive stool occult blood . Pepsinogen level lower limit laboratory reference range ( LLRR ) . Troponin level 10 % coefficient variation assay determine laboratory perform test . For male subject , history hypogonadism treatment associate hypogonadism include radiation therapy testicle . For female subject , positive serum ÃŸhCG ( betahuman chorionic gonadotropin ) pregnancy test . Female subject lactating . Positive urine drug screen ( UDS ) include alcohol . Positive HIV antibody , hepatitis C antibody hepatitis B surface antigen Positive urinary cotinine . Subjects must use nicotinecontaining product , include nicotine patch gum , within past 6 month . Smoking history = 4 pack per day/year smoke within past 12 month . History drug abuse dependence within past 6 month . History alcohol abuse within past 6 month alcohol consumption past 6 month exceed study requirement Presence uncontrolled nausea &amp; vomiting . Presence active infection . Any degree heart failure define New York Heart Association functional classification system . Active peptic ulcer disease ( PUD ) history PUD unknown etiology . Use prescription nonprescription drug ( ) , herbal dietary supplement vitamin within 14 day prior first dose study medication . Consumption food drink contain grapefruit grapefruit juice , apple juice , Seville oranges , kumquat , pomelo vegetable mustard green family ( e.g. , kale , broccoli , watercress , collard green , kohlrabi brussels sprout , mustard ) within 14 day prior first dose study medication . History cholecystectomy biliary tract disease . Any serious unstable preexist medical , psychiatric , condition could interfere subject 's safety , obtain informed consent compliance study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Healthy subject</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Drug interaction</keyword>
	<keyword>Ketoconazole</keyword>
	<keyword>Casopitant</keyword>
</DOC>